{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:23:32Z","timestamp":1770477812626,"version":"3.49.0"},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T00:00:00Z","timestamp":1188950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Granulocytapheresis (GCAP) therapy is a newly developed therapeutic modality for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Pyoderma gangrenosum (PG) is a chronic inflammatory skin disease characterized by the appearance of erythematous macules and plaques with pustules or nodules that rapidly progress to ragged, undermined multiple ulcers. We attempted GCAP therapy in a patient with PG resistant to prednisolone and various other immunosuppressants. GCAP therapy was initiated at three\u2010 to four\u2010day intervals and a good response from all skin lesions, with eventual total epithelialization, was observed after 10 sessions of this therapy. Furthermore, circulating levels of inflammatory cytokines such as interleukin\u20108 (IL\u20108) and granulocyte colony stimulating factor (G\u2010CSF) also decreased after the GCAP therapy. Our results suggest that GCAP is a safe and useful tool for the treatment of intractable PG, and that IL\u20108 and G\u2010CSF are likely to be involved in the pathogenesis of PG.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2007.00498.x","type":"journal-article","created":{"date-parts":[[2007,9,7]],"date-time":"2007-09-07T20:43:40Z","timestamp":1189197820000},"page":"387-390","source":"Crossref","is-referenced-by-count":24,"title":["A Case Report of Steroid and Immunosuppressant\u2010resistant Pyoderma Gangrenosum Successfully Treated by Granulocytapheresis"],"prefix":"10.1111","volume":"11","author":[{"given":"Keiko","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Mitsuishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideoki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigaku","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,5]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.006"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0339"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07657.x"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1774-9987.2005.00229.x"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.1000"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02474-5"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2005.00284.x"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120597"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00795-3"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01986.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20053"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2003.00012.x"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00091.x"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780242"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780064"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2006.04575.x"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2007.00498.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2007.00498.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:22:35Z","timestamp":1697253755000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2007.00498.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1744-9987.2007.00498.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2007.00498.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,5]]}}}